Condition

Advanced Solid Cancers clinical trials and research

• 7Clinical trials
• 7Countries

Newest Advanced Solid Cancers clinical trials

All recruiting trials (7)

• INV-6452 in adults with HR+/HER2- advanced/metastatic breast cancer or other solid tumors

  This study tests INV-6452 to see if it is safe and tolerable and to get a first look at its activity in adults with HR+/HER2- advanced breast cancer or other advanced solid tumors.

  Recruiting Phase 1/2 Shenzhen Ionova Life Sciences Co., Ltd. · Shanghai, Shanghai Municipality · NCT07612891

• Targeted activated dendritic cell plus CAR‑T therapy for advanced solid cancers

  This trial will try combining activated dendritic cells with CAR‑T cells to see if the treatment is safe and helps adults with advanced solid tumors that express Claudin 18.2, GCC, TROP2, or PSMA.

  Recruiting Early Phase 1 Hainan Cancer Hospital · Haikou, Hainan · NCT07475182

• PRL3-zumab treatment for advanced solid cancers

  This Phase II/III study will test whether IV PRL3-zumab (6 mg/kg) given every two weeks can control tumors and is safe in adults with advanced solid cancers.

  Recruiting at 4 sites Phase 2/3 Intra-IMMUSG Pte Ltd · Kota Bharu and 3 other locations · NCT07290088

• ADCX-020 treatment for advanced or metastatic solid tumors

  This trial will test ADCX-020, an antibody–drug conjugate, in adults with advanced or metastatic solid tumors who have run out of standard treatment options.

  Recruiting at 9 sites Phase 1 Adcytherix SAS · Sydney, New South Wales and 8 other locations · NCT07238075

• Testing BNT329 for people with advanced solid tumors that express CA19-9.

  This will test whether the drug BNT329 is safe and might help people with advanced solid tumors that express the CA19-9 marker.

  Recruiting at 18 sites Phase 1/2 BioNTech SE · Denver, Colorado and 17 other locations · NCT07186842

• Testing HS387 in adults with advanced solid tumors (Phase Ia/Ib)

  Doctors are testing a new drug called HS387 to see if it is safe and helps adults with advanced solid tumors who have exhausted or cannot tolerate standard treatments.

  Recruiting Phase 1 Zhejiang Hisun Pharmaceutical Co. Ltd. · Hangzhou, Zhejiang · NCT07092748

• Evaluating SC-102 for advanced solid tumors

  This study is testing a new drug called SC-102 to see if it can safely help people with advanced solid tumors.

  Recruiting Phase 1 Tianjin ConjuStar Biologics Co., Ltd. · Shanghai, Shanghai Municipality · NCT06710158

Related topics

Quick answers

How many Advanced Solid Cancers clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 7 countries. The most sites are in China (4 trials), Australia (2 trials), Spain (2 trials), Malaysia (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 3, Phase 1/2: 2, Phase 2/3: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →